Study: Remdesivir offers no clinical benefit for COVID-19, extends hospital stay for many

Treatment with the the antiviral drug remdesivir offered no clinical benefit to patients hospitalized with COVID-19, even prolonging their stay in healthcare facilities, a study published by JAMA Network Open found.

Source: Health News - UPI.com - July 15, 2021 Category: Consumer Health News Source Type: news